Vessi Medical, which offers cryotherapy technology to treat non muscle invasive bladder cancer (NMIBC), announced it closed a $16.5 million Series A funding round.
The company offers a cryo spray for hollow and humid organs, which it touts as a new treatment approach to NMIBC, a cancer on the surface of the bladder's inner lining.
The Israeli company says its cryotherapy offering is a minimally...
